catamenial epilepsy

Several treatment methods have been determined exclusively for women with catamenial epilepsy.

Some women have a form of epilepsy called catamenial epilepsy.

Notably used on a short-term basis around menstruation in women with catamenial epilepsy.

Women with catamenial epilepsy are unusually sensitive to endogenous hormonal changes.

Estrogen can be found in the female body in various forms, all of which affect women with catamenial epilepsy.

The proper classification for catamenial epilepsy has been debatable for several decades.

Allopregnanolone may serve as an endogenous anticonvulsant and play a role in catamenial epilepsy.

Catamenial epilepsy is the term denoting seizures linked to the menstrual cycle.

Clobazam also has a useful role for very short-term seizure prophylaxis and in catamenial epilepsy.

By this measure, approximately one third of women with epilepsy would be classified under the designation of catamenial epilepsy.

Catamenial epilepsy (CE) is when seizures cluster around certain phases of a woman's menstrual cycle.

Many women with epilepsy have more seizures in a pattern linked to the menstrual cycle; this is called "catamenial epilepsy".

During perimenopause, women with catamenial epilepsy generally experience an increase in seizure frequency, and HRT use does not change this likelihood.

Several studies following HRT use in women with catamenial epilepsy have demonstrated more influencable data than animal models, in this case.

Using one particular definition, one group of scientists found that around one-third of women with intractable partial epilepsy have catamenial epilepsy.

Catamenial epilepsy is a subtype of epilepsy, which is a chronic neurological condition characterized by recurrent seizures.

In a 2009 study, it was found that patients with C1 pattern of catamenial epilepsy had overall lower progesterone levels than healthy controls during the M phase.

The first anticonvulsant was bromide, suggested in 1857 by Charles Locock who used it to treat women with "hysterical epilepsy" (probably catamenial epilepsy).

Catamenial epilepsy is a subset of this population, which includes women of whom their seizure exacerbation is aligned with their menstrual cycle.

These counterbalancing effects may account for "catamenial epilepsy" i.e. epilepsy preceding or made more severe prior to menstruation or during peri-ovulation.

The use of hormone replacement therapy (HRT), such as Premarin, has shown severe negative effects on the seizure patterns of women with catamenial epilepsy.

Changes in the normal levels of this steroid particularly during pregnancy and menstruation may be involved in some types of epilepsy (catamenial epilepsy), as well as stress, anxiety and depression.

If you have seizures that start around the last half of your menstrual cycle and continue through the whole second half of your cycle, then you might have another type of catamenial epilepsy.

Women with epilepsy who do not follow a catamenial pattern may have an unpredictable increase or decrease in seizure activity in perimenopause and menopause, but women with catamenial epilepsy typically follow a more predictable pattern.

Researchers have defined catamenial epilepsy from the broadest definition of a "greater than" approach indicating an increase in seizure frequency or severity during any specific phase of the menstrual cycle, to a "sixfold increase" in average daily seizure frequency during specific times in the cycle.